At last week's Controlled Release Society annual meeting, an
industry analyst looked at nanotechnology and its increasingly
prominent role, but noted that much of what is touted as
nanotechnology actually falls outside the nano-scale.
Germany's Capsulution Nanoscience is tapping into Qiagen's
molecular diagnostics expertise in a collaboration that will
explore new diagnostic and therapeutic possibilities for cancer and
MFIC Corporation, which designs, manufactures and distributes
high-performance Microfluidizer materials-processing equipment for
the biotechnology, pharmaceutical, chemical, cosmetics/personal
care and food industries through its...
A transdermal patch for needle-free delivery of insulin and a
diagnostic test for rapid detection of meningococcal disease are
among the products under development by two new Australian
companies set up to commercialise the research...
US-based nanotech process provider MFIC has announced a 35 per cent
increase in revenue over the full-year 2006 to $15.7m (€12.1m),
driven by a rising demand from drugmakers for microfluidics
UK research organisations, biopharmaceutical and food
manufacturers, along with those in other industries are been asked
to voluntarily provide any information on nanotechnologies they are
working on, under a programme launched this...
A new report warns that as nanotechnology becomes a reality, Europe
must not miss the boat, and raises the alarm that the potential
benefits of nanomedicine in Europe will be lost without major
investment in R&D.
A newly signed research and collaboration agreement between MFIC
Corporation and The University of Massachusetts Lowell (UML) will
facilitate the development of new applications, processes and
products in the growing area of nanomaterials.